Prospective, large‐scale multicenter trial for the use of drug‐coated balloons in coronary lesions: The DCB‐only All‐Comers Registry
- 2 October 2018
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 93 (2) , 181-188
Abstract
Objectives: This prospective, observational all‐comers registry assessed the safety and efficacy of a Drug Coated Balloon‐only strategy (DCB‐only) in patients with coronary lesions.Background: Data regarding the performance of a DCB‐only approach, especially in patients with previously untreated de‐novo coronary artery disease (CAD), are still limited.Methods: This study was conducted as an international, multicenter registry primarily enrolling patients with de‐novo CAD. However, it was also possible to include patients with in‐stent restenosis (ISR). The primary endpoint was the rate of clinically driven target lesion revascularization (TLR) after 9 months.Results: A total of 1,025 patients with a mean age of 64.0 ± 11.2 years were enrolled. The majority of treated lesions were de‐novo (66.9%), followed by drug‐eluting‐stent ISR (DES‐ISR; 22.6%) and bare‐metal‐stent ISR (BMS‐ISR; 10.5%). The TLR rate was lower in the de‐novo group (2.3%) when compared to BMS‐ (2.9%) and DES‐ISR (5.8%) (P = 0.049). Regarding MACE, there was a trend toward fewer events in the de‐novo group (5.6%) than in the BMS‐ (7.8%) and DES‐ISR cohort (9.6%) (P = 0.131). Subgroup analyses revealed that lesion type (95% CI 1.127–6.587); P = 0.026) and additional stent implantation (95% CI 0.054–0.464; P = 0.001) were associated with higher TLR rates.Conclusions: Our results show that DCB‐only angioplasty of de‐novo coronary lesions is associated with low MACE and TLR rates. Thus, DCBs appear to be an attractive alternative for the interventional, stentless treatment of suitable de‐novo coronary lesions.Keywords
Funding Information
- B. Braun Melsungen
This publication has 26 references indexed in Scilit:
- Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus groupClinical Research in Cardiology, 2013
- A Randomized, Multicenter, Single-Blinded Trial Comparing Paclitaxel-Coated Balloon Angioplasty With Plain Balloon Angioplasty in Drug-Eluting Stent RestenosisJACC, 2012
- Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Coated Stent for the Treatment of Coronary In-Stent RestenosisCirculation, 2009
- Treatment of Coronary In-Stent Restenosis with a Paclitaxel-Coated Balloon CatheterNew England Journal of Medicine, 2006
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1994
- Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty.Circulation, 1992
- Emergency stenting for acute occlusion after coronary balloon angioplasty.Circulation, 1988
- Compensatory Enlargement of Human Atherosclerotic Coronary ArteriesNew England Journal of Medicine, 1987
- Nonoperative Dilatation of Coronary-Artery StenosisNew England Journal of Medicine, 1979